Skip to content

Evaluation of changes in quality of life with the use of functional innerwear in patients with atopic dermatitis: a single-arm before-and-after study

Evaluation of changes in quality of life with the use of functional innerwear in patients with atopic dermatitis: a single-arm before-and-after study - Evaluation of changes in quality of life with the use of functional innerwear in patients with atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060316
Enrollment
15
Registered
2026-01-15
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

This study is a single-arm before-and-after study designed to evaluate changes in quality of life and symptoms associated with the use of T-shirts made from a functional fiber (BP) developed by Spiber

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 16 years or older at the time of obtaining informed consent. Patients diagnosed with atopic dermatitis. Patients with mild to moderate disease severity at the time of enrollment (Eczema Area and Severity Index (EASI) under 21).

Exclusion criteria

Exclusion criteria: 1) Patients with serious comorbid conditions, such as severe cardiac, hepatic, renal, pulmonary, or hematologic diseases, that are considered inappropriate for participation in this clinical study. 2) Patients with a current or prior history of malignant neoplasms. However, patients with a history of malignancy who are not receiving active treatment and have remained recurrence-free for at least five years at the time of obtaining informed consent will be eligible for inclusion. 3) Patients who have participated in another post-marketing clinical study within 120 days prior to enrollment (defined as the date of the last administration of an investigational or study drug), or who are currently participating in another clinical study or post-marketing clinical trial. 4) Patients who are otherwise deemed ineligible for participation in this clinical study by the principal investigator or study investigators.

Design outcomes

Primary

MeasureTime frame
DLQI (Dermatology Life Quality Index), Skindex16

Countries

Japan

Contacts

Public ContactAYANO NOMURA

Keio University Department of dermatology

ayano-fukushima@keio.jp0333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026